Excellent short-term CD4 recovery with a PI- and NRTI-sparing regimen in triple-class failure HIV-infected patients: raltegravir, maraviroc, etravirine
暂无分享,去创建一个
A. Lazzarin | L. Galli | F. Visco | A. Castagna | G. Tambussi | S. Nozza | N. Gianotti | A. Bigoloni | A. Soria | G. Fusetti | S. Salpietro | E. Carini